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Abstract
Background: The aim of this study was to investigate the presence of multidrug resistant yeasts in the faeces of
synanthropic wild birds from the Bangsar suburb of Kuala Lumpur.
Methods: Species characterisations of yeast isolates and determinations of antimycotic susceptibility profiles were
undertaken using the commercial characterization kit, Integral System Yeasts Plus (Liofilchem, Italy).
Results: Fourteen species of yeasts were detected in the bird faecal samples.Candida albicans was present in
28.89% of bird faecal samples, Candida krusei (13.33%), Candida tropicalis (4.44%), Candida glabrata (4.44%), Candida
parapsilosis (2.22%), Candida lambica (2.22%), Candida stellatoidea (2.22%), Candida rugosa (2.22%) and Candida
lusitaniae (2.22%). Amongst the non-candidal yeast isolates, Cryptococcus laurentii was present in 6.67% of bird
faecal samples, Cryptococcus uniguttulatus (4.44%), Saccharomyces cerevisiae (4.44%), Trichosporon pullulans (2.22%),
Trichosporon pullulans/Cryptococcus albidus (8.89%) and Rhodotorula rubra/Rhodotorula glutinis (4.44%). Of the
isolated yeasts, 18.1% (or 26/144) were found to be resistant to all 11 antimycotic agents they were tested against
i.e. Nystatin, Amphotericin B, Flucytosine, Econazole, Ketoconazole, Clotrimazole, Miconazole, Itraconazole,
Voriconazole, Fluconazole 16 and Fluconazole 64. 45.8% (or 66/144) of the bird faecal yeast isolates were resistant
to four or more of the 11 antimycotic agents they were tested against.
Conclusions: This finding is of public health significance as these synanthropic wild birds may be reservoirs for
transmission of drug resistant yeast infections to humans.
Background
Wild birds that inhabit urban regions have long been
known to harbour human pathogens with zoonotic
potential. Amongst reported cases are Listeria monocy-
togenes in wild birds around Helsinki [1], Chlamydo-
phila psittaci in pigeons and other free-living species in
Zagreb [2], Campylobacter spp. in ducks in Washington
[3], Salmonella spp. in gulls in the Czech Republic [4],
pathogenic Escherichia coli, Enterobacter cloacae, Sal-
monella spp., Aeromonas hydrophilia and Providencia
alcalifaciens in Canada geese found in London parks
[5], Cryptosporidium spp. and Giardia spp. in Canada
geese in Maryland [6], Eimeria magnalabia (3%),
Eimeria hermani (14%), Eimeria truncata (2%) and Tyz-
zeria parvula in Canada geese in Ontario [7], Histo-
plasma capsulatum in chickens, pigeons, starlings,
blackbirds and bats [8] and West Nile Virus in urban
birds in Georgia [9]. In Malaysia, a recent study done
by Hwee Yong et al [10] showed the presence of the
Enterobacteriaceae and protozoan parasites in the stool
of the large billed Crow (Corvus spp.) in Kuala Lumpur.
Perhaps the best known example occurring globally is
the current situation with Highly Pathogenic Avian
Influenza Virus (HPAIV) in poultry and migratory wild
birds [11]. As such, although the presence of these
birds, upon occasion, is aesthetically pleasing in parks
and recreational bodies of water, and without doubt,
they do function as pollinators within cities, large num-
bers when present, particularly in the vicinity of high
risk areas such as hospitals, are a potential health
hazard.
This study focuses on the Bangsar area, an affluent
residential suburb of Kuala Lumpur, the capital city of
Malaysia. It is heavily populated and endowed with
numerous open air restaurants and road side food stalls.
Many of the sampling sites chosen for this study were
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tial to become contaminated with pathogens that were
harboured in bird faeces that littered the surrounding
areas. Bangsar also boasts one major hospital, clinics
and other nearby hospitals.
Methods
Sample collection
A total of 45 wild bird faecal samples were collected
from 12 designated sampling sites from the Bangsar
suburb of Kuala Lumpur. Collection of bird faecal sam-
ples from these sites was randomised. Fresh faecal sam-
ples were collected at two week intervals at 7 pm when
the wild birds came to roost for the night. Faecal sam-
ples were loaded into eppendorf tubes containing sterile
Sabouraud’s Dextrose Broth supplemented with 0.5 g/L
chloramphenicol (SDB-chmp) to inhibit bacterial
growth. Samples were stored in a cooler box and trans-
ported to the research laboratory immediately. Upon
arrival, samples were weighed, vortexed briefly, then
stored at 4°C before processing.
Viability Assay
Cold stored samples were vortexed and plated onto
Sabouraud’s Dextrose Agar plates supplemented with
0.5 g/L chloramphenicol (SDA-chmp). Immediately after
plating, plates were incubated at 37°C in the dark for
five days. On the sixth day of incubation, viable counts
were taken. Counts were expressed as x CFU per millili-
ter fresh weight faeces.
Species characterizations and determinations of
antimycotic susceptibility profiles
From each of the 45 faecal samples, seven isolates were
randomly selected from the SDA-chmp viability assay
plates and subcultured twice for purification. Species
characterisations of these isolates and determinations of
antimycotic susceptibility profiles were undertaken using
the commercial characterization kit, Integral System
Yeasts Plus (Liofilchem, Italy).
Results
Fourteen species of yeasts were detected (Additional
File 1).Candida albicans was present in 28.89% of bird
faecal samples, Candida krusei (13.33%), Candida tropi-
calis (4.44%), Candida glabrata (4.44%), Candida para-
psilosis (2.22%), Candida lambica (2.22%), Candida
stellatoidea (2.22%), Candida rugosa (2.22%) and Can-
dida lusitaniae (2.22%). Amongst the non-candidal yeast
isolates, Cryptococcus laurentii was present in 6.67% of
bird faecal samples, Cryptococcus uniguttulatus (4.44%),
Saccharomyces cerevisiae (4.44%), Trichosporon pullu-
lans (2.22%), Trichosporon pullulans/Cryptococcus
albidus (8.89%) and Rhodotorula rubra/Rhodotorula glu-
tinis (4.44%).
A significant proportion of the yeasts isolated from the
bird faecal samples were found to be drug resistant or
multidrug resistant (Additional Files 2, 3, 4, 5, 6, 7, 8, 9,
10, 11, 12, 13, 14, 15, 16). 18.1% (or 26/144) were found
to be resistant to all 11 of the antimycotic agents they
were tested against. 45.8% (or 66/144) of the bird faecal
yeast isolates were resistant to four or more of the 11
antimycotic agents they were tested against (Table 1).
The following proportions of isolates demonstrated
resistance to four or more antimycotic agents: 13.2% (or
7/53) of the C. albicans isolates, 33.3% (or 1/3) of the C.
glabrata isolates, 85.7% (or 6/7) of the C. krusei isolates,
66.7% (or 2/3) of the C. lusitaniae isolates, all (or 2/2)
Table 1 Proportion and percentage of drug resistant and
multidrug resistant bird faecal yeast isolates by genus/
species
Genus/Species Isolates resistant to all
11 antimycotic agents
Isolates resistant to four
or more antimycotic
agents
Proportion Percentage
(%)
Proportion Percentage
(%)
All genera/
species
26/144 18.1 66/144 45.8
Candida 1/75 1.3 19/75 25.3
C. albicans 0/53 0.0 7/53 13.2
C. parapsilosis 0/3 0.0 0/3 0.0
C. tropicalis 0/2 0.0 2/2 100.0
C. lambica 0/1 0.0 0/1 0.0
C. stellatoidea 1/1 100.0 1/1 100.0
C. glabrata 0/3 0.0 1/3 33.3
C. krusei 0/7 0.0 6/7 85.7
C. rugosa 0/2 0.0 0/2 0.0
C. lusitaniae 0/3 0.0 2/3 66.7
Cryptococcus 8/10 80.0 8/10 80.0
Cryptococcus
uniguttulatus
0/2 0.0 0/2 0.0
Cryptococcus
laurentii
8/8 100.0 8/8 100.0
Saccharomyces
cerevisiae
0/5 0 0/5 0.0
Trichosporon
pullulans
2/2 100 2/2 100.0
Trichosporon
pullulans/
Cryptococcus
albidus
7/8 87.5 7/8 87.5
Rhodotorula
rubra/
Rhodotorula
glutinis
0/5 0 2/5 40.0
Unidentified 9/39 23.1 27/39 69.2
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latoidea isolates. Of the noncandidal isolates, 100% (or
8/8) of the Cryptococcus laurentii isolates, 100% (or 2/2)
of the T. pullulans isolates, 87.5% (or 7/8) of the
T. pullulans/C. albidus isolates, 40% (or 2/5) of the
R. rubra/R. glutinis isolates and 69.2% (or 27/39) of
the unidentified yeast isolates were resistant to four or
more antimycotic agents.
Discussion
The findings of this study indicate the presence of mul-
tidrug resistant yeasts in the faeces of synanthropic wild
birds in Bangsar. Furthermore, many of the species of
yeasts detected are documented human pathogens with
zoonotic potential [12].
28.89% of the bird faecal samples harboured C. albi-
cans and this was the most prevalent species of yeast in
the faecal samples. European surveys indicate that this
s p e c i e si sr e s p o n s i b l ef o rm o r et h a nh a l ft h ec a s e so f
invasive candidaemia; however, the occurrence of non-
albicans related disease appears to be increasing [13].
During the past decade there has been an increasing
trend of systemic and fatal infections with non albicans
species such as Candida tropicalis, Candida glabrata,
Candida parapsilosis, Candida lusitaniae and Candida
lipolytica. Identification of these species is essential for
effective therapy in view of the emergence of resistance
to antifungal drugs in these species [14].Candida para-
psilosis is a major emerging human pathogen that has
dramatically increased in significance and prevalence
over the past two decades, and is now one of the leading
causes of invasive candidal disease. Individuals at the
highest risk for severe infection include neonates and
patients in intensive care units [15].
Non-neoformans cryptococci have traditionally been
thought of as saprophytes but the incidence of human
infection with these species has increased with Crypto-
coccus laurentii and Cryptococcus albidus together
responsible for 80% of non-neoformans reported cases
[16]. These species are emerging fungal pathogens to be
reckoned with. All eight C. laurentii isolates obtained
from this study were resistant to all 11 of the antimyco-
tic agents they were tested against. C. laurentii has been
reported as a rare cause of CAPD associated peritonitis,
pulmonary and cutaneous infections [17], fungaemia in
a premature neonate [18] and invasive disease in a nine-
year-old boy with X-linked hyper-immunoglobulin M
syndrome [19]. C. albidus has been reported to cause
cutaneous infections [20], eye and blood infections in
HIV patients [21], pulmonary infection and fungaemia
in a leukaemia patient [22] and mucormycosis empyema
in a haemodialysis patient [23].
It has been reported that antifungal primary prophy-
laxis with either itraconazole or fluconazole is effective
in reducing the incidence of cryptococcal disease in
adults with advanced HIV disease [24]. The results of
this study are of concern as the C. laurentii isolates
obtained are resistant to both itraconazole, fluconazole
and all the other antimycotic agents they were tested
against.
Rhodotorula rubra has been implicated in patients suf-
fering from meningitis and keratitis, albeit in the debili-
tated and the immunocompromised [25,26].
Rhodotorula glutinis on the other hand has been
reported to cause meningitis in an immunocompetent
patient [27]. Trichosporon pullulans has been reported
to have caused pulmonary infection in a leukaemia
patient [28], infections in a renal transplant patient [29]
and in two patients with chronic granulomatous disease
[30], amongst others.
Perhaps what may also be significant are the isolates
that have not been identified as they were beyond the
resolving power of the commercial identification kit
used. 69.2% of them were resistant to four or more anti-
mycotic agents. Some of these isolates may be human
pathogens or may have the potential of being human
pathogens.
Nosocomial fungal infections are seen to be increas-
ingly significant amongst the critically ill. Fungi are now
amongst the most frequently isolated organisms in
intensive care units. Reports describe potentially fatal
fungal infections that are resistant to many commonly
used antifungal agents [31], reminiscent of the drug
resistant and multidrug resistant yeasts isolated in this
study. It is therefore important to recognize and mini-
mize the major risk factors associated with infection,
including the existence of synanthropic animal reser-
voirs. This study supports previous reports that describe
the potential of synanthropic birds as carriers, reservoirs
and disseminators of pathogens.
In the Bangsar area, the predominant species of bird
are wild crows. Not being of the domesticated variety,
these birds would not have encountered antifungal che-
motherapy. As such, the drug resistant yeasts obtained
in this study are either originally human strains that
evolved resistance during human therapy with antifun-
gals and subsequently were disseminated to these wild
birds, or alternatively, different mechanisms of antifun-
gal resistance development are at work. Possibly, poly-
specific transporters, if they exist in these drug resistant
yeasts, may have evolved in response to toxins/poisons
that are commonly encountered by the birds that har-
bour these yeasts, either in the wild or in the cities
where they frequently dwell. As such, it would be of
epidemiological interest to determine whether (1) sylva-
tic crows living in proximity to Bangsar harbour simi-
larly drug resistant strains of yeasts, and (2) whether the
drug resistant yeast strains obtained in this study are
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ciated with hospitals in the vicinity of the study site.
While mass culling and disposal is the well
prescribed method of dealing with contagion in
domesticated and wild animals, it is expensive, labour-
intensive and does not in any way address the root
causes of the problem. As such, it is not a long-term
solution and when applied, often does not prevent
recurrence of the problem. If colonization with these
yeasts is directly associated with the immune status of
the birds, then the root of the problem lies in the
factors that lower bird vitality. The latter include
ecological changes that result from urbanization and
growth of megacities, and the lack of or breakdown in
sanitation that often ensues. Chemical pollution, noise
pollution and climate change as a result of shifting
temperatures and precipitation levels, are yet other
potential contributory factors to colonization and the
emergence of disease, by way of modifying both bird
and microbial behaviour.
Conclusions
This study demonstrates that synanthropic wild birds in
the Bangsar area harbour multidrug resistant Cryptococ-
cus laurentii and other drug resistant and multidrug
resistant yeasts. Both the candidal and noncandidal yeast
species isolated have been associated with opportunistic
and disseminated infections in man, particularly in those
with some form of underlying immune suppression,
including those on high-dose corticosteroid therapy,
having neutropenia or human immunodeficiency virus
(HIV) infection [32-35]. In view of the burgeoning
immunosuppressed populations both in Malaysia and
globally [36,37], the existence and evolution of drug
resistant and multidrug resistant strains of yeasts in
synanthropic birds that commonly inhabit urban
regions, is a source of public health concern.
Additional file 1: Chart showing the percentage of wild bird faecal
samples that were positive for the genus/species of yeast (n = 45); mean
load (m) of each genus/species in positive samples in CFU/ml faeces and
range (r) are given in the boxes.
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